Literature DB >> 273926

Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).

J H Griffin.   

Abstract

The mechanism by which negatively charged substances such as celite, kaolin, or ellagic acid contribute to the surface-dependent activation of Hageman factor (Factor XII) was studied. Kinetic studies of the proteolytic activation of (125)I-labeled human Hageman factor by human plasma kallikrein, plasma, activated Factor XI, and trypsin were performed in the presence and absence of high molecular weight kininogen and surface materials such as celite, kaolin, or ellagic acid. The results showed that surface-bound Hageman factor was 500 times more susceptible than soluble Hageman factor to proteolytic activation by kallikrein in the presence of high molecular weight kininogen. Surface binding of Hageman factor enhanced its cleavage by plasmin, activated Factor XI, and trypsin by 100-fold, 30-fold, and 5-fold, respectively. On a molar basis, trypsin was twice as potent as kallikrein in the cleavage of the surface-bound Hageman factor, while plasmin and activated Factor XI were an order of magnitude less potent than kallikrein. Kallikrein even at concentrations as low as 0.5 nM (i.e., 1/1000th of the concentration of prekallikrein in plasma) was very potent in the limited proteolysis of the surface-bound Hageman factor. These results suggest that substances classically known as "activating surfaces" promote the activation of Hageman factor indirectly by altering its structure such that it is much more susceptible to proteolytic activation by other plasma or cellular proteases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 273926      PMCID: PMC392470          DOI: 10.1073/pnas.75.4.1998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Characterization of bovine factor XIIa (activated Hageman factor).

Authors:  K Fujikawa; K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1977-09-20       Impact factor: 3.162

2.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

Authors:  H L Meier; J V Pierce; R W Colman; A P Kaplan
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.

Authors:  B N Bouma; J H Griffin
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

4.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.

Authors:  S D Revak; C G Cochrane; J H Griffin
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

5.  Flaujeac trait. Deficiency of human plasma kininogen.

Authors:  K D Wuepper; D R Miller; M J Lacombe
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa.

Authors:  R Radcliffe; Y Nemerson
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

7.  Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.

Authors:  R C Wiggins; B N Bouma; C G Cochrane; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

8.  Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.

Authors:  B N Bouma; J H Griffin
Journal:  J Lab Clin Med       Date:  1978-01

9.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.

Authors:  S D Revak; C G Cochrane; B N Bouma; J H Griffin
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  51 in total

Review 1.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

2.  Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death.

Authors:  Robert Silasi; Ravi Shankar Keshari; Cristina Lupu; Walter Janse Van Rensburg; Hala Chaaban; Girija Regmi; Aleksandr Shamanaev; Joseph J Shatzel; Cristina Puy; Christina U Lorentz; Erik I Tucker; David Gailani; András Gruber; Owen J T McCarty; Florea Lupu
Journal:  Blood Adv       Date:  2019-02-26

3.  Competitive-protein adsorption in contact activation of blood factor XII.

Authors:  Rui Zhuo; Christopher A Siedlecki; Erwin A Vogler
Journal:  Biomaterials       Date:  2007-07-20       Impact factor: 12.479

4.  Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.

Authors:  Francesc Calafell; Laura Almasy; Maria Sabater-Lleal; Alfonso Buil; Carolina Mordillo; Anna Ramírez-Soriano; Martin Sikora; Juan Carlos Souto; John Blangero; Jordi Fontcuberta; José Manuel Soria
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

Review 5.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 6.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

7.  Surface dependent contact activation of factor XII and blood plasma coagulation induced by mixed thiol surfaces.

Authors:  James W Bauer; Li-Chong Xu; Erwin A Vogler; Christopher A Siedlecki
Journal:  Biointerphases       Date:  2017-05-17       Impact factor: 2.456

8.  A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.

Authors:  Yasin Kokoye; Ivan Ivanov; Qiufang Cheng; Anton Matafonov; S Kent Dickeson; Shauna Mason; Daniel J Sexton; Thomas Renné; Keith McCrae; Edward P Feener; David Gailani
Journal:  Thromb Res       Date:  2016-02-18       Impact factor: 3.944

9.  Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.

Authors:  N J Mutch; E K Waters; J H Morrissey
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

10.  Combined cis-regulator elements as important mechanism affecting FXII plasma levels.

Authors:  Maria Sabater-Lleal; Miguel Chillón; Carolina Mordillo; Angel Martínez; Estel Gil; José Mateo; John Blangero; Laura Almasy; Jordi Fontcuberta; José Manuel Soria
Journal:  Thromb Res       Date:  2009-09-27       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.